Advertisement

Cambridge Major Laboratories, Inc Company Profile

13:00 EDT 22nd May 2013 | BioPortfolio

Welcome to 2006! I would like to update you with our accomplishments of 2005 and share with you our plans and goals for 2006. In general, 2005 brought continued changes in the pharmaceutical market: more consolidation within Big Pharma, a further shift of manufacturing to the Chinese and Indian markets, and on the positive side, more pronounced growth of mid-sized pharmaceutical and Biotech companies. It appears that in the very near future most of the manufacturing and early stage synthesis of scaffolds will be sole domain of the off shore companies. On the other hand IP-sensitive, R&D-intensive, and generally time-critical projects will stay in the US where the scientifically-fittest companies have the best chance at succeeding.

Location

W130 N10497 Washington Drive
Germantown
Wisconsin
53022
United States of America

Contact

Phone: 262-251-5044
Fax: 262-251-5577
Email: info@c-mlabs.com


News Articles [ 606 Associated News Articles listed on BioPortfolio]

American Capital commits $212 million to acquire Cambridge Major Laboratories

Private equity firm American Capital (Nasdaq: ACAS) says that it has committed $212 million in the buyout of USA-based Cambridge Major Laboratories, a global provider of complex chemistry-based outsou...

API launch from new Cambridge Major Laboratories facility

This is the first commercial launch of an active pharmaceutical ingredient from its newest facility

Piramal in Talks to Buy US Contract Drug Maker Cambridge for $200 M [

Piramal in Talks to Buy US Contract Drug Maker Cambridge for $200 M [Financial Express (India)] From Financial Express (India) (June 16, 2012) Piramal Healthcare (PHL) is in talks to buy US contract d...

Cambridge Major expands large-scale API capacity at US site

Cambridge Major Laboratories (CML) has announced a significant expansion of its large-scale API manufacturing facility in Germantown, Wisconsin, USA. The company says this is in response to continued...

Cambridge facility to become worldwide hub for SAFC's chiral service

Sigma-Aldrich Corporation today announced that its custom manufacturing and services business unit, SAFC, will consolidate its global chiral chromatography screening and small scale purification opera...

Major India Drug Makers Lead Pharma Investment In Malaysia Market

India's Biocon, Cipla, Dr. Reddy's Laboratories, Ranbaxy Laboratories and Strides Arcolab are major investors in Malaysia's pharmaceutical market as they seek increased exports to Southeast Asia natio...

Contract manufacturing facility additions: round-up

Outsourcing-Pharma.com brings you a round-up of the latest contract manufacturing facility additions, including news from Boehringer Ingelheim, Cambridge Major Laboratories, and B. Braun Group.

Cambridge Major Adds Significant Capacity at US Site

Following continued growth in demand for larger scale Active Pharmaceutical Ingredient (API) manufacturing services, Cambridge Major Laboratories (CML) is announcing a significant...

PubMed Articles [ 395 Associated PubMed Articles listed on BioPortfolio]

Food addiction: is there a baby in the bathwater?

Adipogenesis at a glance.

Structure-based fragment screening is demonstrated to be a practical lead discovery method for a representative g-protein-coupled receptor.

Obesity and the brain: how convincing is the addiction model?

An increasingly influential perspective conceptualizes both obesity and overeating as a food addiction accompanied by corresponding brain changes. Because there are far-reaching implications for clini...

FTO and Obesity: The Missing Link.

Genome-wide association studies revealed that variants within FTO (fat-mass- and obesity-associated) are strongly associated with obesity susceptibility. A recent study in Nature Genetics (Church et ...

Clinical Trials [ 1091 Associated Clinical Trials listed on BioPortfolio]

Compassionate Use of Tetrabenazine in the Treatment of Abnormal Movements

Although the results of studies looking at tetrabenazine have shown its effectiveness in the management of hyperkinetic(too much) movement disorders, it has not been made available in the...

Bioequivalence Study of Meloxicam Tablets 15 mg of Dr.Reddy's Laboratories Limited Under Fed Condition

The objective of this study is to determine the relative bioavailability of one 15 mg Meloxicam tablet (Dr. Reddy. Laboratories Ltd.,Generics) versus one 15 mg Mobic (meloxicam) Tablet (Bo...

Bioequivalence Study of Dr.Reddy's Laboratories Limited Finasteride Tablets 1 mg Under Fed Condition

The objective of this study was to compare the single-dose relative bioavailability of Dr. Reddy's Laboratories, Ltd. and Merck & Co. (Propecia®) 1 mg finasteride tablets under fed condi...

Bioequivalence Study of Meloxicam Tablets 15 mg of Dr.Reddy's Laboratories Limited Under Fasting Condition

The objective of this study is to determine the relative bioavailability of one 15 mg Meloxicam tablet (Dr. Reddy. Laboratories Ltd.,Generics) versus one 15 mg Mobic (meloxicam) Tablet (Bo...

Bioequivalence Study of Dr. Reddy's Laboratories Limited, Finasteride Tablets 1 mg Under Fasting Condition

The objective of this study was to compare the single-dose relative bioavailability of Dr. Reddy's Laboratories, Ltd. and Merck & Co. (Propecia®) 1 mg finasteride tablets under fasting c...

Companies [ 1678 Associated Companies listed on BioPortfolio]

Cambridge Major Laboratories, Inc.

Signet Laboratories, Inc.

Signet Laboratories, Inc. (Signet, Dedham, MA) is a leading medical diagnostics/research company specializing in the development of monoclonal antibodies and diagnostics assays for cancer, infectious...

Cambridge Cognition Ltd

Cambridge Cognition Ltd specialises in computerised cognitive testing. Based in Cambridge, England, the company supplies products and services based on CANTAB®, the Cambridge Neuropsychological Test...

Funxional Therapeutics Limited

Funxional Therapeutics is a privately held, clinical stage pharmaceutical company based in Cambridge (UK) which focuses on novel anti-inflammatory therapies. FXT is managed by a very experienced t...

MISSION Therapeutics Ltd

MISSION Therapeutics was founded in 2011 by a team of scientists including Professor Steve Jackson, Dr Niall Martin, Dr Xavier Jacq and Dr Keith Menear, along with founding institutes Cancer Researc...

More Information about "Cambridge Major Laboratories, Inc" on BioPortfolio

We have published hundreds of Cambridge Major Laboratories, Inc news stories on BioPortfolio along with dozens of Cambridge Major Laboratories, Inc Clinical Trials and PubMed Articles about Cambridge Major Laboratories, Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cambridge Major Laboratories, Inc Companies in our database. You can also find out about relevant Cambridge Major Laboratories, Inc Drugs and Medications on this site too.

Search BioPortfolio:
Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record

Advertisement